A detailed history of Paulson Wealth Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Paulson Wealth Management Inc. holds 1,888 shares of AMGN stock, worth $496,883. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,888
Previous 1,906 0.94%
Holding current value
$496,883
Previous $595,000 2.18%
% of portfolio
0.16%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $5,568 - $6,072
-18 Reduced 0.94%
1,888 $608,000
Q2 2024

Jul 25, 2024

SELL
$262.75 - $319.31 $6,306 - $7,663
-24 Reduced 1.24%
1,906 $595,000
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $7,797 - $9,412
29 Added 1.53%
1,930 $548,000
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $269,507 - $304,036
-1,054 Reduced 35.67%
1,901 $547,000
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $220,836 - $274,174
1,010 Added 51.93%
2,955 $794,000
Q2 2023

Aug 01, 2023

BUY
$214.27 - $253.37 $150,417 - $177,865
702 Added 56.48%
1,945 $431,000
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $42,900 - $52,288
190 Added 18.04%
1,243 $300,000
Q4 2022

Jan 26, 2023

BUY
$229.03 - $291.01 $241,168 - $306,433
1,053 New
1,053 $0
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $3,922 - $4,364
-17 Reduced 1.29%
1,305 $318,000
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $17,980 - $19,890
82 Added 6.61%
1,322 $320,000
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $246,611 - $282,224
1,240 New
1,240 $279,000
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $254,895 - $303,535
-1,178 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$234.65 - $260.95 $276,417 - $307,399
1,178 New
1,178 $299,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Paulson Wealth Management Inc. Portfolio

Follow Paulson Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paulson Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paulson Wealth Management Inc. with notifications on news.